LOC730101: A Potential Drug Target and Biomarker (G730101)

Target Name: LOC730101

NCBI ID: G730101

LOC730101

Other Name(s): uncharacterized LOC730101 | Uncharacterized LOC730101, transcript variant 2 | Uncharacterized LOC730101, transcript variant 1

LOC730101: A Potential Drug Target and Biomarker

LOC730101 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the superfamily of transmembrane protein (SMP), which includes a variety of structurally diverse proteins that are involved in a wide range of cellular processes. One of the most interesting aspects of LOC730101 is its potential as a drug target or biomarker.

The protein encoded by the LOC730101 gene is approximately 120 amino acids long and has a calculated pI of approximately 6.5. It is located in the endoplasmic reticulum (ER) and is predominantly expressed in the brain, heart, and kidneys. LOC730101 is involved in a number of cellular processes, including the regulation of ion and water transport, as well as the maintenance of cell structure and signaling pathways.

One of the most promising aspects of LOC730101 is its potential as a drug target. The ability of LOC730101 to be expressed in various tissues and the fact that it is involved in a wide range of cellular processes make it an attractive target for drug development. Additionally, LOC730101 has been shown to interact with a variety of molecules, including transcription factors, which further increases its potential as a drug target.

LOC730101 has also been shown to be a potential biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and cardiovascular disease. The expression of LOC730101 has been observed in a variety of cancer types, including breast, ovarian, and prostate cancer. Additionally, LOC730101 has been shown to be expressed in the brains of individuals with neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. This suggests that it may be a useful biomarker for these conditions as well.

In conclusion, LOC730101 is a protein that has a wide range of potential applications as a drug target or biomarker. Its ability to be expressed in various tissues and its involvement in a wide range of cellular processes make it an attractive target for drug development. Additionally, its potential as a biomarker for a variety of diseases makes it an important molecule to study further. Further research is needed to fully understand the potential of LOC730101 as a drug target or biomarker.

Protein Name: Uncharacterized LOC730101

The "LOC730101 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC730101 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets